{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:08:41Z","timestamp":1777320521778,"version":"3.51.4"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"30","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Sci Pollut Res"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11356-020-12200-1","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T04:27:45Z","timestamp":1610684865000},"page":"40431-40444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications"],"prefix":"10.1007","volume":"28","author":[{"given":"Rajnish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janmejai Kumar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Haris","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-7840","authenticated-orcid":false,"given":"Md. Sahab","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotfi","family":"Aleya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"12200_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.coviro.2014.06.002","volume":"8","author":"AO Adedeji","year":"2014","unstructured":"Adedeji AO, Sarafianos SG (2014) Antiviral drugs specific for coronaviruses in preclinical development. Curr Opin Virol 8:45\u201353. https:\/\/doi.org\/10.1016\/j.coviro.2014.06.002","journal-title":"Curr Opin Virol"},{"issue":"2","key":"12200_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00221-18","volume":"9","author":"ML Agostini","year":"2018","unstructured":"Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X et al (2018) Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio 9(2):1\u201315. https:\/\/doi.org\/10.1128\/mBio.00221-18","journal-title":"mBio"},{"key":"12200_CR3","doi-asserted-by":"publisher","unstructured":"Agrawal S, Goel AD, Gupta N (2020) Emerging prophylaxis strategies against COVID-19. Monaldi Arch Chest Dis 90(1). https:\/\/doi.org\/10.4081\/monaldi.2020.1289","DOI":"10.4081\/monaldi.2020.1289"},{"issue":"1","key":"12200_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/jac\/dkh519","volume":"55","author":"GW Amsden","year":"2005","unstructured":"Amsden GW (2005) Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 55(1):10\u201321. https:\/\/doi.org\/10.1093\/jac\/dkh519","journal-title":"J Antimicrob Chemother"},{"key":"12200_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ecoenv.2016.10.029","volume":"136","author":"M Ashfaq","year":"2017","unstructured":"Ashfaq M, Nawaz Khan K, Saif Ur Rehman M, Mustafa G, Faizan Nazar M, Sun Q, Iqbal J, Mulla SI, Yu CP (2017) Ecological risk assessment of pharmaceuticals in the receiving environment of pharmaceutical wastewater in Pakistan. Ecotoxicol Environ Saf 136:31\u201339. https:\/\/doi.org\/10.1016\/j.ecoenv.2016.10.029","journal-title":"Ecotoxicol Environ Saf"},{"key":"12200_CR6","doi-asserted-by":"publisher","first-page":"118075","DOI":"10.1016\/j.lfs.2020.118075","volume":"257","author":"T Behl","year":"2020","unstructured":"Behl T, Kaur I, Bungau S, Kumar A, Uddin MS, Kumar C, Pal G, Sahil, Shrivastava K, Zengin G, Arora S (2020) The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions. Life Sci 257:118075. https:\/\/doi.org\/10.1016\/j.lfs.2020.118075","journal-title":"Life Sci"},{"key":"12200_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1465-9921-11-90","volume":"11","author":"A Beigelman","year":"2010","unstructured":"Beigelman A, Mikols CL, Gunsten SP, Cannon CL, Brody SL, Walter MJ (2010) Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis. Respir Res 11:90. https:\/\/doi.org\/10.1186\/1465-9921-11-90","journal-title":"Respir Res"},{"key":"12200_CR8","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1021\/jm0601856","volume":"49","author":"C Biot","year":"2006","unstructured":"Biot C, Daher W, Chavain N, Fandeur T, Khalife J, Dive D, De Clercq E (2006) Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem 49:2845\u20132849. https:\/\/doi.org\/10.1021\/jm0601856","journal-title":"J Med Chem"},{"issue":"6","key":"12200_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJMoa2016638","volume":"383","author":"DR Boulware","year":"2020","unstructured":"Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH (2020) A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med 383(6):517\u2013525. https:\/\/doi.org\/10.1056\/NEJMoa2016638","journal-title":"N Engl J Med"},{"key":"12200_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2019.104541","volume":"169","author":"AJ Brown","year":"2019","unstructured":"Brown AJ, Won JJ, Graham RL, Dinnon KH, Sims AC, Feng JY, Cihlar T, Denison MR et al (2019) Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antivir Res 169:1\u201310. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104541","journal-title":"Antivir Res"},{"issue":"11","key":"12200_CR11","first-page":"57","volume":"8","author":"M Cammaerts","year":"2020","unstructured":"Cammaerts M, Cammaerts R (2020) Side effects of chloroquine and hydroxychloroquine examined on ants as models. EC Pharmacol Toxicol 8(11):57\u201382","journal-title":"EC Pharmacol Toxicol"},{"key":"12200_CR12","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","volume":"383","author":"AB Cavalcanti","year":"2020","unstructured":"Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, Damiani LP, Marcadenti A, Kawano-Dourado L, Lisboa T, Junqueira DLM, de Barros e Silva PGM, Tramujas L, Abreu-Silva EO, Laranjeira LN, Soares AT, Echenique LS, Pereira AJ, Freitas FGR, Gebara OCE, Dantas VCS, Furtado RHM, Milan EP, Golin NA, Cardoso FF, Maia IS, Hoffmann Filho CR, Kormann APM, Amazonas RB, Bocchi de Oliveira MF, Serpa-Neto A, Falavigna M, Lopes RD, Machado FR, Berwanger O (2020) Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19. N Engl J Med 383:2041\u20132052. https:\/\/doi.org\/10.1056\/NEJMoa2019014","journal-title":"N Engl J Med"},{"issue":"2","key":"12200_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1101\/2020.03.22.20040758","volume":"49","author":"Z Chen","year":"2020","unstructured":"Chen Z, Hu J, Zhang Z, Jiang S, Han S, Yan D, Zhuang R et al (2020a) Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. J Zhejiang Univ (Med Sci) 49(2):215\u2013219. https:\/\/doi.org\/10.1101\/2020.03.22.20040758","journal-title":"J Zhejiang Univ (Med Sci)"},{"key":"12200_CR14","doi-asserted-by":"publisher","unstructured":"Chen J, Liu D, Liu L, Liu P, Xu Q, Lu X, Ling Y, Huang D, Song S, Zhang D, Qian Z et al (2020b) A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (covid-19). J Zhejiang Univ (Med Sci) 49(1). https:\/\/doi.org\/10.3785\/j.issn.1008-9292.2020.03.03","DOI":"10.3785\/j.issn.1008-9292.2020.03.03"},{"issue":"4","key":"12200_CR15","doi-asserted-by":"publisher","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","volume":"55","author":"P Colson","year":"2020","unstructured":"Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D (2020) Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents 55(4):105932. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105932","journal-title":"Int J Antimicrob Agents"},{"key":"12200_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.chemosphere.2019.05.032","volume":"230","author":"H Dabic","year":"2019","unstructured":"Dabic H, Babic S, Skoric I (2019) The role of photodegradation in the environmental fate of hydroxychloroquine. Chemosphere 230:268\u2013277","journal-title":"Chemosphere"},{"key":"12200_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.scitotenv.2013.06.111","volume":"466-467","author":"CG Daughton","year":"2014","unstructured":"Daughton CG (2014) The Matthew effect and widely prescribed pharmaceuticals lacking environmental monitoring: case study of an exposure-assessment vulnerability. Sci Total Environ 466-467:315\u2013325. https:\/\/doi.org\/10.1016\/j.scitotenv.2013.06.111","journal-title":"Sci Total Environ"},{"key":"12200_CR18","doi-asserted-by":"publisher","first-page":"108019","DOI":"10.1016\/j.heares.2020.108019","volume":"395","author":"SN Davis","year":"2020","unstructured":"Davis SN, Wu P, Camci ED, Simon JA, Rubel EW, Raible DW (2020) Chloroquine kills hair cells in zebrafish lateral line and murine cochlear cultures: implications for ototoxicity. Hear Res 395:108019. https:\/\/doi.org\/10.1016\/j.heares.2020.108019","journal-title":"Hear Res"},{"key":"12200_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.20529\/IJME.2020.040","volume":"V(2)","author":"M D'Cruz","year":"2020","unstructured":"D'Cruz M (2020) The ICMR bulletin on targeted hydroxychloroquine prophylaxis for Covid-19: need to interpret with caution. Indian J Med Ethics V(2):100\u2013102. https:\/\/doi.org\/10.20529\/IJME.2020.040","journal-title":"Indian J Med Ethics"},{"issue":"12","key":"12200_CR20","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1073\/pnas.1922083117","volume":"117","author":"E de Wit","year":"2020","unstructured":"de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, Scott D, Cihlar T, Feldmann H (2020) Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S A 117(12):6771\u20136776. https:\/\/doi.org\/10.1073\/pnas.1922083117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"12200_CR21","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s40265-018-1010-7","volume":"78","author":"ED Deeks","year":"2018","unstructured":"Deeks ED (2018) Bictegravir\/emtricitabine\/tenofovir alafenamide: a review in HIV-1 infection. Drugs 78(17):1817\u20131828. https:\/\/doi.org\/10.1007\/s40265-018-1010-7","journal-title":"Drugs"},{"issue":"20","key":"12200_CR22","doi-asserted-by":"publisher","first-page":"30098","DOI":"10.1016\/j.drudis.2020.02.011","volume":"S1359-6446","author":"Y Duan","year":"2020","unstructured":"Duan Y, Zhu HL, Zhou C (2020) Advance of promising targets and agents against COVID-19 in China. Drug Discov Today S1359-6446(20):30098\u201330102. https:\/\/doi.org\/10.1016\/j.drudis.2020.02.011","journal-title":"Drug Discov Today"},{"key":"12200_CR23","unstructured":"Fass (2020) Plaquenil\u00ae. Accessed: 15 November 2020. Available at: https:\/\/www.fass.se\/LIF\/product?-1.ILinkListener-documentTabPanel-tabs-panel-article~tools~top-articletools-printlink&userType=2&nplId=19610412000017&docType=78&docTypeDynTab=78"},{"issue":"20","key":"12200_CR24","doi-asserted-by":"publisher","first-page":"30262","DOI":"10.1016\/S1473-3099(20)30262-0","volume":"S1473-3099","author":"EG Favalli","year":"2020","unstructured":"Favalli EG, Biggioggero M, Maioli G, Caporali R (2020) Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis S1473-3099(20):30262\u201330270. https:\/\/doi.org\/10.1016\/S1473-3099(20)30262-0","journal-title":"Lancet Infect Dis"},{"key":"12200_CR25","unstructured":"FDA (2020) Fact sheet for health care providers emergency use authorization (EUA) of hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of Covid-19 in certain hospitalized patients. Available at: https:\/\/www.fda.gov\/media\/136537\/download.\u00a0Accessed 15 Nov 2020"},{"key":"12200_CR26","doi-asserted-by":"publisher","first-page":"m1432","DOI":"10.1136\/bmj.m1432","volume":"369","author":"RE Ferner","year":"2020","unstructured":"Ferner RE, Aronson JK (2020) Chloroquine and hydroxychloroquine in covid-19. BMJ 369:m1432. https:\/\/doi.org\/10.1136\/bmj.m1432","journal-title":"BMJ"},{"issue":"11","key":"12200_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.9790\/3013-04011053064","volume":"4","author":"L Ferraz","year":"2014","unstructured":"Ferraz L, Santos F, Ferreira A, Junior RTLM, Rosa TA, Rolim LA, Rolim-Neto PJ (2014) Clinical, pharmacokinetic and technological aspects of the hydroxychloroquine sulfate. IOSR J Pharm 4(11):53\u201364. https:\/\/doi.org\/10.9790\/3013-04011053064","journal-title":"IOSR J Pharm"},{"issue":"3","key":"12200_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/vaccines4030023","volume":"4","author":"SB Fleming","year":"2016","unstructured":"Fleming SB (2016) Viral inhibition of the IFN-induced JAK\/STAT signalling pathway: development of live attenuated vaccines by mutation of viral-encoded IFN-antagonists. Vaccines (Basel) 4(3):23. https:\/\/doi.org\/10.3390\/vaccines4030023","journal-title":"Vaccines (Basel)"},{"key":"12200_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12967-020-02339-3","volume":"18","author":"B Fu","year":"2020","unstructured":"Fu B, Xu X, Wei H (2020) Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med 18:164. https:\/\/doi.org\/10.1186\/s12967-020-02339-3","journal-title":"J Transl Med"},{"key":"12200_CR30","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1177\/0961203396005001041","volume":"1","author":"DE Furst","year":"1996","unstructured":"Furst DE (1996) Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases. Lumpus Suppl 1:S11\u2013S15. https:\/\/doi.org\/10.1177\/0961203396005001041","journal-title":"Lumpus Suppl"},{"key":"12200_CR31","doi-asserted-by":"publisher","unstructured":"Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honor\u00e9 S, Colson P, Chabri\u00e8re E, La Scola B, Rolain JM et al (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents:105949. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105949","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"12200_CR32","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","volume":"382","author":"J Geleris","year":"2020","unstructured":"Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson D, Kubin C, Barr RG, Sobieszczyk ME, Schluger NW (2020) Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 382:2411\u20132418. https:\/\/doi.org\/10.1056\/NEJMoa2012410","journal-title":"N Engl J Med"},{"issue":"3","key":"12200_CR33","doi-asserted-by":"publisher","DOI":"10.3171\/2014.12.FOCUS14748","volume":"38","author":"EB Golden","year":"2015","unstructured":"Golden EB, Cho HY, Hofman FM, Louie SG, Sch\u00f6nthal AH, Chen TC (2015) Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors. Neurosurg Focus 38(3):E12. https:\/\/doi.org\/10.3171\/2014.12.FOCUS14748","journal-title":"Neurosurg Focus"},{"key":"12200_CR34","doi-asserted-by":"publisher","first-page":"4307e4314","DOI":"10.1021\/es1032629","volume":"45","author":"C Gon\u00e7alves","year":"2011","unstructured":"Gon\u00e7alves C, Perez S, Osorio V, Petrovic M, Alpendurada MF, Barcelo D (2011) Photofate of oseltamivir (Tamiflu) and oseltamivir carboxylate under naturaland simulated solar irradiation: kinetics, identification of the transformationproducts, and environmental occurrence. Environ Sci Technol 45:4307e4314\u20134307e4314. https:\/\/doi.org\/10.1021\/es1032629","journal-title":"Environ Sci Technol"},{"issue":"15","key":"12200_CR35","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","volume":"295","author":"CJ Gordon","year":"2020","unstructured":"Gordon CJ, Tchesnokov EP, Feng JY, Porter DP, Gotte M (2020) The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem 295(15):4773\u20134779. https:\/\/doi.org\/10.1074\/jbc.AC120.013056","journal-title":"J Biol Chem"},{"key":"12200_CR36","doi-asserted-by":"publisher","unstructured":"Guastalegname M, Vallone A (2020) Could chloroquine \/hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment? Clin Infect Dis ciaa321. https:\/\/doi.org\/10.1093\/cid\/ciaa321","DOI":"10.1093\/cid\/ciaa321"},{"key":"12200_CR37","doi-asserted-by":"publisher","first-page":"6230","DOI":"10.1093\/emboj\/17.21.6230","volume":"17","author":"H Hacker","year":"1998","unstructured":"Hacker H, Mischak H, Miethke T, Liptay S, Schmid R et al (1998) CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 17:6230\u20136240. https:\/\/doi.org\/10.1093\/emboj\/17.21.6230","journal-title":"EMBO J"},{"key":"12200_CR38","doi-asserted-by":"publisher","unstructured":"Hasana S, Hossain MF, Jalouli M, Kabir MT, Uddin MG, Wahed MII, Behl T, Bin-Jumah MN, Abdel-Daim MM, Aleya L, Uddin MS (2021) Genetic Diversity of SARS-CoV2 and environmental\u00a0settings: possible association with neurological disorders. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-020-02239-z","DOI":"10.1007\/s12035-020-02239-z"},{"issue":"6","key":"12200_CR39","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/jac\/dkh002","volume":"52","author":"H Hemil\u00e4","year":"2003","unstructured":"Hemil\u00e4 H (2003) Vitamin C and SARS coronavirus. J Antimicrob Chemother 52(6):1049\u20131050. https:\/\/doi.org\/10.1093\/jac\/dkh002","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"12200_CR40","first-page":"756","volume":"3","author":"H Hemil\u00e4","year":"1999","unstructured":"Hemil\u00e4 H, Douglas RM (1999) Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis 3(9):756\u2013761","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10223","key":"12200_CR41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"issue":"3","key":"12200_CR42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jmii.2020.03.034","volume":"53","author":"SS Jean","year":"2020","unstructured":"Jean SS, Lee PI, Hsueh PR (2020) Treatment options for COVID-19: the reality and challenges. J Microbiol Immunol Infect 53(3):436\u2013443. https:\/\/doi.org\/10.1016\/j.jmii.2020.03.034","journal-title":"J Microbiol Immunol Infect"},{"key":"12200_CR43","doi-asserted-by":"publisher","unstructured":"Jeon S, Ko M, Lee J, Choi I, Byun SY, Park S, Shum D, Kim S (2020) Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. bioRxiv. https:\/\/doi.org\/10.1101\/2020.03.20.999730","DOI":"10.1101\/2020.03.20.999730"},{"key":"12200_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13075-018-1634-8","volume":"20","author":"AM Jorge","year":"2018","unstructured":"Jorge AM, Melles RB, Zhang Y, Lu N, Rai SK, Young LH, Costenbader KH, Ramsey-Goldman R, Lim SS, Esdaile JM, Clarke AE, Urowitz MB, Askanase A, Aranow C, Petri M, Choi H (2018) Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines. Arthritis Res Ther 20:133. https:\/\/doi.org\/10.1186\/s13075-018-1634-8","journal-title":"Arthritis Res Ther"},{"key":"12200_CR45","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3389\/fcell.2020.00616","volume":"8","author":"MT Kabir","year":"2020","unstructured":"Kabir MT, Uddin MS, Hossain MF, Abdulhakim JA, Alam MA, Ashraf GM, Bungau SG, Bin-Jumah MN, Abdel-Daim MM, Aleya L (2020) nCOVID-19 pandemic: from molecular pathogenesis to potential investigational therapeutics. Front Cell Dev Biol 8:616. https:\/\/doi.org\/10.3389\/fcell.2020.00616","journal-title":"Front Cell Dev Biol"},{"key":"12200_CR46","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/CMR.00078-09","volume":"23","author":"S Kanoh","year":"2010","unstructured":"Kanoh S, Rubin BK (2010) Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 23:590\u2013615. https:\/\/doi.org\/10.1128\/CMR.00078-09","journal-title":"Clin Microbiol Rev"},{"key":"12200_CR47","doi-asserted-by":"publisher","first-page":"215e223","DOI":"10.2131\/jts.38.215","volume":"38","author":"K Kawabata","year":"2013","unstructured":"Kawabata K, Sugihara K, Sanoh S, Kitamura S, Ohta S (2013) Photodegradation of pharmaceuticals in the aquatic environment by sunlight and UV-A, -B and -Cirradiation. J Toxicol Sci 38:215e223\u2013215e223. https:\/\/doi.org\/10.2131\/jts.38.215","journal-title":"J Toxicol Sci"},{"issue":"2","key":"12200_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/jps.2600660244","volume":"66","author":"SA Khalil","year":"1977","unstructured":"Khalil SA (1977) Effect of chloroquine adsorption on acid reactivity of magnesium trisilicate. J Pharm Sci 66(2):289\u2013290. https:\/\/doi.org\/10.1002\/jps.2600660244","journal-title":"J Pharm Sci"},{"issue":"8","key":"12200_CR49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/BF02976712","volume":"26","author":"KA Kim","year":"2003","unstructured":"Kim KA, Park JY, Lee JS, Lim S (2003) Cytochrome P450 2C8 and CYP3A4\/5 are involved in chloroquine metabolism in human liver microsomes. Arch Pharm Res 26(8):631\u2013637. https:\/\/doi.org\/10.1007\/BF02976712","journal-title":"Arch Pharm Res"},{"issue":"4","key":"12200_CR50","doi-asserted-by":"publisher","first-page":"105933","DOI":"10.1016\/j.ijantimicag.2020.105933","volume":"55","author":"WC Ko","year":"2020","unstructured":"Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, Hsueh PR (2020) Arguments in favor of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents 55(4):105933. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105933","journal-title":"Int J Antimicrob Agents"},{"issue":"20","key":"12200_CR51","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa030781","volume":"348","author":"TG Ksiazek","year":"2003","unstructured":"Ksiazek TG, Erdman D, Goldsmith CS (2003) A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348(20):1953\u20131966. https:\/\/doi.org\/10.1056\/NEJMoa030781","journal-title":"N Engl J Med"},{"issue":"2","key":"12200_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1389200216666151103121352","volume":"17","author":"R Kumar","year":"2016","unstructured":"Kumar R, Sharma A, Siddiqui MH, Tiwari RK (2016) Prediction of metabolism of drugs using artificial intelligence: how far have we reached? Curr Drug Metab 17(2):129\u2013141. https:\/\/doi.org\/10.2174\/1389200216666151103121352","journal-title":"Curr Drug Metab"},{"key":"12200_CR53","doi-asserted-by":"publisher","first-page":"582025","DOI":"10.3389\/fphar.2020.582025","volume":"11","author":"R Kumar","year":"2020","unstructured":"Kumar R, Srivastava JK, Singh R, Siddiqui MH, Mansouri RA, Abdulhakim JA, Bin-Jumah MN, Alkahtani S, Abdel-Daim MM, Uddin MS (2020) Available compounds with therapeutic potential against COVID-19: antimicrobial therapies, supportive care, and probable vaccines. Front Pharmacol 11:582025. https:\/\/doi.org\/10.3389\/fphar.2020.582025","journal-title":"Front Pharmacol"},{"issue":"5","key":"12200_CR54","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.0954-6820.1982.tb01971.x","volume":"211","author":"I Leden","year":"1982","unstructured":"Leden I (1982) Digoxin-hydroxychloroquine interaction? Acta Med Scand 211(5):411\u20134122. https:\/\/doi.org\/10.1111\/j.0954-6820.1982.tb01971.x","journal-title":"Acta Med Scand"},{"key":"12200_CR55","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","volume":"9","author":"AJ Lee","year":"2018","unstructured":"Lee AJ, Ashkar AA (2018) The dual nature of type I and type II interferons. Front Immunol 9:2061. https:\/\/doi.org\/10.3389\/fimmu.2018.02061","journal-title":"Front Immunol"},{"issue":"1","key":"12200_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/MEJ.0b013e3280adcb56","volume":"15","author":"A Ling Ngan Wong","year":"2008","unstructured":"Ling Ngan Wong A, Tsz Fung Cheung I, Graham CA (2008) Hydroxychloroquine overdose: case report and recommendations for management. Eu J Emerg Med 15(1):16\u201318. https:\/\/doi.org\/10.1097\/MEJ.0b013e3280adcb56","journal-title":"Eu J Emerg Med"},{"issue":"2","key":"12200_CR57","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jgg.2020.02.001","volume":"47","author":"X Liu","year":"2020","unstructured":"Liu X, Wang XJ (2020) Potential inhibitors for 2019-nCoV coronavirus M protease from clinically proven medicines. J Genet Genomics 47(2):119\u2013121. https:\/\/doi.org\/10.1016\/j.jgg.2020.02.001","journal-title":"J Genet Genomics"},{"key":"12200_CR58","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","volume":"6","author":"J Liu","year":"2020","unstructured":"Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, Li Y, Hu Z, Zhong W, Wang M (2020) Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov 6:16. https:\/\/doi.org\/10.1038\/s41421-020-0156-0","journal-title":"Cell Discov"},{"key":"12200_CR59","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/JCMA.0000000000000318","volume":"83","author":"CC Lu","year":"2020","unstructured":"Lu CC, Chen MY, Chang YL (2020) Potential therapeutic agents against COVID-19: what we know so far. J Chin Med Assoc 83:534\u2013536. https:\/\/doi.org\/10.1097\/JCMA.0000000000000318","journal-title":"J Chin Med Assoc"},{"issue":"5","key":"12200_CR60","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/jgh.15053","volume":"35","author":"RN Lui","year":"2020","unstructured":"Lui RN, Wong SH, S\u00e1nchez-Luna SA, Pellino G, Bollipo S, Wong MY, Chiu PWY, Sung JJY (2020) Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic. J Gastroenterol Hepatol 35(5):749\u2013759. https:\/\/doi.org\/10.1111\/jgh.15053","journal-title":"J Gastroenterol Hepatol"},{"key":"12200_CR61","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/jmv.25801","volume":"92","author":"P Luo","year":"2020","unstructured":"Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J (2020) Tocilizumab treatment in COVID-19: a single center experience. J Med Virol 92:814\u2013818. https:\/\/doi.org\/10.1002\/jmv.25801","journal-title":"J Med Virol"},{"key":"12200_CR62","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4049\/jimmunol.160.3.1122","volume":"160","author":"DE Macfarlane","year":"1998","unstructured":"Macfarlane DE, Manzel L (1998) Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J Immunol 160:1122\u20131131","journal-title":"J Immunol"},{"key":"12200_CR63","doi-asserted-by":"publisher","unstructured":"Mack HG (2020) Hydroxychloroquine use during the COVID-19 pandemic 2020. Aust J Gen Pract 49. https:\/\/doi.org\/10.31128\/AJGP-COVID-08","DOI":"10.31128\/AJGP-COVID-08"},{"issue":"2","key":"12200_CR64","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","volume":"118","author":"MF Marmor","year":"2011","unstructured":"Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF (2011) Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118(2):415\u2013422. https:\/\/doi.org\/10.1016\/j.ophtha.2010.11.017","journal-title":"Ophthalmology"},{"key":"12200_CR65","doi-asserted-by":"publisher","unstructured":"Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, Shimojima M, Fukushi S (2020) The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15. bioRxiv. https:\/\/doi.org\/10.1101\/2020.03.11.987016","DOI":"10.1101\/2020.03.11.987016"},{"key":"12200_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0002-9343(83)91265-2","volume":"75","author":"EW McChesney","year":"1983","unstructured":"McChesney EW (1983) Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. Am J Med 75:11\u201318. https:\/\/doi.org\/10.1016\/0002-9343(83)91265-2","journal-title":"Am J Med"},{"issue":"4","key":"12200_CR67","first-page":"159","volume":"85","author":"JC McElnay","year":"1982","unstructured":"McElnay JC, Mukhtar HA, D'Arcy PF, Temple DJ, Collier PS (1982) The effect of magnesium trisilicate and kaolin on the in vivo absorption of chloroquine. J Trop Med Hyg 85(4):159\u2013163","journal-title":"J Trop Med Hyg"},{"issue":"12","key":"12200_CR68","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/nm.3985","volume":"21","author":"VD Menachery","year":"2015","unstructured":"Menachery VD, Yount BL Jr, Debbink K, Agnihothram S, Gralinski LE, Plante JA, Graham RL, Scobey T, Ge XY, Donaldson EF, Randell SH, Lanzavecchia A, Marasco WA, Shi ZL, Baric RS (2015) SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med 21(12):1508\u20131513. https:\/\/doi.org\/10.1038\/nm.3985","journal-title":"Nat Med"},{"issue":"5","key":"12200_CR69","doi-asserted-by":"publisher","first-page":"e639","DOI":"10.1016\/S2214-109X(20)30114-5","volume":"8","author":"O Mitj\u00e0","year":"2020","unstructured":"Mitj\u00e0 O, Clotet B (2020) Use of antiviral drugs to reduce COVID-19 transmission. Lancet Glob Health 8(5):e639\u2013e640. https:\/\/doi.org\/10.1016\/S2214-109X(20)30114-5","journal-title":"Lancet Glob Health"},{"issue":"20","key":"12200_CR70","doi-asserted-by":"publisher","first-page":"30085","DOI":"10.1016\/j.medmal.2020.03.006","volume":"S0399-077X","author":"JM Molina","year":"2020","unstructured":"Molina JM, Delaugerre C, Le Goff J, Mela-Lima B, Ponscarme D, Goldwirt L, de Castro N (2020) No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Med Mal Infect S0399-077X(20):30085\u201330088. https:\/\/doi.org\/10.1016\/j.medmal.2020.03.006","journal-title":"Med Mal Infect"},{"issue":"8","key":"12200_CR71","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1089\/jir.2014.0021","volume":"34","author":"SC Nallar","year":"2014","unstructured":"Nallar SC, Kalvakolanu DV (2014) Interferons, signal transduction pathways, and the central nervous system. J Interf Cytokine Res 34(8):559\u2013576. https:\/\/doi.org\/10.1089\/jir.2014.0021","journal-title":"J Interf Cytokine Res"},{"issue":"1","key":"12200_CR72","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/jac\/dkg319\/10.1159\/000187007","volume":"62","author":"MR Nampoory","year":"1992","unstructured":"Nampoory MR, Nessim J, Gupta RK, Johny KV (1992) Drug interaction of chloroquine with ciclosporin. Nephron 62(1):108\u2013109. https:\/\/doi.org\/10.1093\/jac\/dkg319\/10.1159\/000187007","journal-title":"Nephron"},{"key":"12200_CR73","unstructured":"National Health Commission of the People's Republic of China Interpretation of COVID-19 treatment guidelines (6th version) (2020). http:\/\/www.gov.cn\/zhengce\/2020-02\/19\/content_5480958.htm. Accessed 6 November 2020"},{"key":"12200_CR74","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/rheumatology\/15.3.235","volume":"15","author":"AJ Popert","year":"1976","unstructured":"Popert AJ (1976) Choloroquine: a review. Rheumatology 15:235\u2013238. https:\/\/doi.org\/10.1093\/rheumatology\/15.3.235","journal-title":"Rheumatology"},{"key":"12200_CR75","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.toxrep.2017.11.006","volume":"5","author":"M Ramesh","year":"2017","unstructured":"Ramesh M, Anitha S, Poopal RK, Shobana C (2017) Evaluation of acute and sublethal effects of chloroquine (C18H26CIN3) on certain enzymological and histopathological biomarker responses of a freshwater fish Cyprinus carpio. Toxicol Rep 5:18\u201327. https:\/\/doi.org\/10.1016\/j.toxrep.2017.11.006","journal-title":"Toxicol Rep"},{"key":"12200_CR76","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S1473-3099(20)30313-3","volume":"20","author":"S Rathi","year":"2020","unstructured":"Rathi S, Ish P, Kalantri A, Kalantri S (2020) Hydroxychloroquine prophylaxis for COVID-19 contacts in India. The Lancet Infect Dis 20:1118\u20131119. https:\/\/doi.org\/10.1016\/S1473-3099(20)30313-3","journal-title":"The Lancet Infect Dis"},{"key":"12200_CR77","doi-asserted-by":"publisher","unstructured":"Richardson PJ, Corbellino M, Stebbing J (2020) Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis S1473:3099(20)30270-X. https:\/\/doi.org\/10.1016\/S1473-3099(20)30270-X","DOI":"10.1016\/S1473-3099(20)30270-X"},{"key":"12200_CR78","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ijantimicag.2007.05.015","volume":"30","author":"JM Rolain","year":"2007","unstructured":"Rolain JM, Colson P, Raoult D (2007) Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents 30:297\u2013308. https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.05.015","journal-title":"Int J Antimicrob Agents"},{"key":"12200_CR79","doi-asserted-by":"publisher","unstructured":"Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J et al (2020) Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state. JAMA:e208630. https:\/\/doi.org\/10.1001\/jama.2020.8630","DOI":"10.1001\/jama.2020.8630"},{"key":"12200_CR80","doi-asserted-by":"publisher","unstructured":"Rubin EJ, Harrington DP, Hogan JW, Gatsonis C, Baden LR et al (2020) The urgency of care during the Covid-19 pandemic - learning as we go. N Engl J Med. NEJMe2015903. https:\/\/doi.org\/10.1056\/NEJMe2015903","DOI":"10.1056\/NEJMe2015903"},{"issue":"4","key":"12200_CR81","doi-asserted-by":"publisher","first-page":"105945","DOI":"10.1016\/j.ijantimicag.2020.105945","volume":"55","author":"Z Sahraei","year":"2020","unstructured":"Sahraei Z, Shabani M, Shokouhi S, Saffaei A (2020) Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine. Int. J. Antimicrob. Agents 55(4):105945. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105945","journal-title":"Int. J. Antimicrob. Agents"},{"key":"12200_CR82","unstructured":"Sanofi (2020) Important information on Plaquenil\u00ae\/Quensyl\u00ae\/Plaquinol\u00ae (hydroxychloroquine) and COVID-19. Available at:\u00a0https:\/\/www.sanofi.com\/en\/about-us\/our-stories\/important-information-on-plaquenil-quensyl-plaquinol-COVID-19.\u00a0Accessed 15 Nov 2020"},{"key":"12200_CR83","unstructured":"Sanofi internal report (2016) Hydroxychloroquine (CAS N\u00b0118\u201342-3) Ready Biodegradability \u201cManometric Respirometry. OECD 301F. Report BPL15\u20130032 EB"},{"key":"12200_CR84","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S1473-3099(06)70361-9","volume":"2006","author":"A Savarino","year":"2006","unstructured":"Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A (2006) New insights into the antiviral effects of chloroquine. Lancet Infect Dis 2006:667\u2013169. https:\/\/doi.org\/10.1016\/S1473-3099(06)70361-9","journal-title":"Lancet Infect Dis"},{"key":"12200_CR85","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16:155\u2013166. https:\/\/doi.org\/10.1038\/s41584-020-0372-x","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"12200_CR86","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1001\/jamainternmed.2020.2594","volume":"180","author":"N Shehab","year":"2020","unstructured":"Shehab N, Lovegrove M, Budnitz DS (2020) US hydroxychloroquine, chloroquine, and azithromycin outpatient prescription trends, October 2019 through March 2020. JAMA Intern Med 180(10):1384\u20131386. https:\/\/doi.org\/10.1001\/jamainternmed.2020.2594","journal-title":"JAMA Intern Med"},{"issue":"9","key":"12200_CR87","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3390\/plants9091244","volume":"9","author":"AJ Siddiqui","year":"2020","unstructured":"Siddiqui AJ, Danciu C, Ashraf SA, Moin A, Singh R, Alreshidi M, Patel M, Jahan S, Kumar S, Alkhinjar MIM, Badraoui R, Snoussi M, Adnan M (2020a) Plants-derived biomolecules as potent antiviral phytomedicines: new insights on ethnobotanical evidences against coronaviruses. Plants (Basel) 9(9):1244. https:\/\/doi.org\/10.3390\/plants9091244","journal-title":"Plants (Basel)"},{"key":"12200_CR88","doi-asserted-by":"publisher","unstructured":"Siddiqui AJ, Jahan S, Ashraf SA, Alreshidi M, Ashraf MS, Patel et al (2020b) Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2. J Biomol Struct Dyn:1\u201314. https:\/\/doi.org\/10.1080\/07391102.2020.1802345","DOI":"10.1080\/07391102.2020.1802345"},{"issue":"SI-1","key":"12200_CR89","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3906\/sag-2004-145","volume":"50","author":"S \u015eim\u015fek Yavuz","year":"2020","unstructured":"\u015eim\u015fek Yavuz S, \u00dcnal S (2020) Antiviral treatment of COVID-19. Turk J Med Sci 50(SI-1):611\u2013619. https:\/\/doi.org\/10.3906\/sag-2004-145","journal-title":"Turk J Med Sci"},{"issue":"3","key":"12200_CR90","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.dsx.2020.03.011","volume":"14","author":"AK Singh","year":"2020","unstructured":"Singh AK, Singh A, Shaikh A, Singh R, Misra A (2020) Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab Syndr 14(3):241\u2013246. https:\/\/doi.org\/10.1016\/j.dsx.2020.03.011","journal-title":"Diabetes Metab Syndr"},{"key":"12200_CR91","doi-asserted-by":"publisher","unstructured":"Sinha N, Balayla G (2020) Hydroxychloroquine and covid-19. Postgrad Med J postgradmedj-2020:137785. https:\/\/doi.org\/10.1136\/postgradmedj-2020-137785","DOI":"10.1136\/postgradmedj-2020-137785"},{"issue":"6","key":"12200_CR92","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1046\/j.1365-2125.2000.00197.x","volume":"49","author":"M Somer","year":"2000","unstructured":"Somer M, Kallio J, Pesonen U, Pyykk\u00f6 K, Huupponen R, Scheinin M (2000) Influence of hydroxychloroquine on the bioavailability of oral metoprolol. Br J Clin Pharmacol 49(6):549\u2013554. https:\/\/doi.org\/10.1046\/j.1365-2125.2000.00197.x","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"12200_CR93","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","volume":"20","author":"J Stebbing","year":"2020","unstructured":"Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P (2020) COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 20(4):400\u2013402. https:\/\/doi.org\/10.1016\/S1473-3099(20)30132-8","journal-title":"Lancet Infect Dis"},{"key":"12200_CR94","volume-title":"StatPearls","author":"TJ Stokkermans","year":"2020","unstructured":"Stokkermans TJ, Trichonas G (2020) Chloroquine and hydroxychloroquine toxicity. In: StatPearls. StatPearls Publishing, Treasure Island"},{"key":"12200_CR95","doi-asserted-by":"publisher","first-page":"37707","DOI":"10.1039\/D0RA06379G","volume":"10","author":"M Surti","year":"2020","unstructured":"Surti M, Patel M, Adnan M, Moinc A, Ashraf SA et al (2020) Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study. RSC Adv 10:37707\u201337720. https:\/\/doi.org\/10.1039\/D0RA06379G","journal-title":"RSC Adv"},{"key":"12200_CR96","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.antiviral.2017.11.017","volume":"149","author":"YW Tan","year":"2018","unstructured":"Tan YW, Yam WK, Sun J, Chu JJH (2018) An evaluation of chloroquine as a broad-acting antiviral against Hand, Foot and Mouth Disease. Antivir Res 149:143\u2013149. https:\/\/doi.org\/10.1016\/j.antiviral.2017.11.017","journal-title":"Antivir Res"},{"key":"12200_CR97","doi-asserted-by":"publisher","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","volume":"177","author":"F Touret","year":"2020","unstructured":"Touret F, de Lamballerie X (2020) Of chloroquine and COVID-19. Antivir Res 177:104762. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104762","journal-title":"Antivir Res"},{"key":"12200_CR98","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"MJ Vincent","year":"2005","unstructured":"Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG, Nichol ST (2005) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2:69. https:\/\/doi.org\/10.1186\/1743-422X-2-69","journal-title":"Virol J"},{"issue":"10223","key":"12200_CR99","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang C, Horby PW, Hayden FG, Gao F (2020a) A novel coronavirus outbreak of global health concern. Lancet 395(10223):470\u2013473. https:\/\/doi.org\/10.1016\/S0140-6736(20)30185-9","journal-title":"Lancet"},{"key":"12200_CR100","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zang L, Yang X, Liu J (2020b) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30:269\u2013271. https:\/\/doi.org\/10.1038\/s41422-020-0282-0","journal-title":"Cell Res"},{"issue":"2","key":"12200_CR101","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jac\/dkg319","volume":"52","author":"DC Warhurst","year":"2003","unstructured":"Warhurst DC, Steele JC, Adagu IS, Craig JC, Cullander C (2003) Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties. J Antimicrob Chemother 52(2):188\u2013193. https:\/\/doi.org\/10.1093\/jac\/dkg319","journal-title":"J Antimicrob Chemother"},{"key":"12200_CR102","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","volume":"531","author":"TK Warren","year":"2016","unstructured":"Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, Larson N, Strickley R, Wells J, Stuthman KS, van Tongeren SA, Garza NL, Donnelly G, Shurtleff AC, Retterer CJ, Gharaibeh D, Zamani R, Kenny T, Eaton BP, Grimes E, Welch LS, Gomba L, Wilhelmsen CL, Nichols DK, Nuss JE, Nagle ER, Kugelman JR, Palacios G, Doerffler E, Neville S, Carra E, Clarke MO, Zhang L, Lew W, Ross B, Wang Q, Chun K, Wolfe L, Babusis D, Park Y, Stray KM, Trancheva I, Feng JY, Barauskas O, Xu Y, Wong P, Braun MR, Flint M, McMullan LK, Chen SS, Fearns R, Swaminathan S, Mayers DL, Spiropoulou CF, Lee WA, Nichol ST, Cihlar T, Bavari S (2016) Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531:381\u2013385. https:\/\/doi.org\/10.1038\/nature17180","journal-title":"Nature"},{"key":"12200_CR103","doi-asserted-by":"publisher","first-page":"5214751","DOI":"10.1155\/2020\/5214751","volume":"2020","author":"DZ Wondafrash","year":"2020","unstructured":"Wondafrash DZ, Desalegn TZ, Yimer EM, Tsige AG, Adamu BA, Zewdie KA (2020) Potential effect of hydroxychloroquine in diabetes mellitus: a systematic review on preclinical and clinical trial studies. J Diabetes Res 2020:5214751\u20135214710. https:\/\/doi.org\/10.1155\/2020\/5214751","journal-title":"J Diabetes Res"},{"key":"12200_CR104","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"C Wu","year":"2020","unstructured":"Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M, Chen L, Li H (2020) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B 10:766\u2013788. https:\/\/doi.org\/10.1016\/j.apsb.2020.02.008","journal-title":"Acta Pharm Sin B"},{"key":"12200_CR105","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/cr.2012.165","volume":"23","author":"Y Yan","year":"2013","unstructured":"Yan Y, Zou Z, Sun Y, Li X, Xu KF, Wei Y, Jin N, Jiang C (2013) Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res 23:300\u2013302. https:\/\/doi.org\/10.1038\/cr.2012.165","journal-title":"Cell Res"},{"key":"12200_CR106","doi-asserted-by":"publisher","unstructured":"Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E et al (2020) In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis:ciaa237. https:\/\/doi.org\/10.1093\/cid\/ciaa237","DOI":"10.1093\/cid\/ciaa237"},{"key":"12200_CR107","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.7326\/M20-1334","volume":"172","author":"J Yazdany","year":"2020","unstructured":"Yazdany J, Kim AHJ (2020) Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know. Ann Intern Med 172:M20\u2013M1334. https:\/\/doi.org\/10.7326\/M20-1334","journal-title":"Ann Intern Med"},{"key":"12200_CR108","doi-asserted-by":"publisher","unstructured":"Yu B, Li C, Chen P, Zhou N, Wang L, Li J et al (2020) Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19. https:\/\/doi.org\/10.1101\/2020.04.27.20073379","DOI":"10.1101\/2020.04.27.20073379"},{"issue":"19","key":"12200_CR109","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki AM, Van Boheemen S, Bestebroer TM (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367(19):1814\u20131820. https:\/\/doi.org\/10.1056\/NEJMoa1211721","journal-title":"N Engl J Med"},{"issue":"5","key":"12200_CR110","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00228-011-1161-x","volume":"68","author":"P Zarogoulidis","year":"2012","unstructured":"Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K (2012) Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory disease. Eur J Clin Pharmacol 68(5):479\u2013503. https:\/\/doi.org\/10.1007\/s00228-011-1161-x","journal-title":"Eur J Clin Pharmacol"},{"key":"12200_CR111","doi-asserted-by":"publisher","first-page":"105955","DOI":"10.1016\/j.ijantimicag.2020.105955","volume":"105955","author":"P Zhai","year":"2020","unstructured":"Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y (2020) The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 105955:105955. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105955","journal-title":"Int J Antimicrob Agents"},{"key":"12200_CR112","doi-asserted-by":"publisher","unstructured":"Zhang J, Wang W, Peng B, Peng W, Zhang Y, Wang Y, Wan Y, Chang J et al (2020) Potential of Arbidol for post-exposure prophylaxis of COVID-19 transmission. ChinaXiv:202002.00065. https:\/\/doi.org\/10.12074\/202002.00065","DOI":"10.12074\/202002.00065"},{"key":"12200_CR113","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41256-020-00135-6","volume":"5","author":"H Zhu","year":"2020","unstructured":"Zhu H, Wei L, Niu P (2020) The novel coronavirus outbreak in Wuhan, China. Glob Health Res Policy 5:6. https:\/\/doi.org\/10.1186\/s41256-020-00135-6","journal-title":"Glob Health Res Policy"},{"issue":"2","key":"12200_CR114","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.aquatox.2005.07.009","volume":"75","author":"JL Zurita","year":"2005","unstructured":"Zurita JL, Jos A, del Peso A, Salguero M, L\u00f3pez-Art\u00edguez M, Repetto G (2005) Ecotoxicological evaluation of the antimalarial drug chloroquine. Aquat Toxicol 75(2):97\u2013107. https:\/\/doi.org\/10.1016\/j.aquatox.2005.07.009","journal-title":"Aquat Toxicol"}],"container-title":["Environmental Science and Pollution Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-020-12200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11356-020-12200-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-020-12200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T19:19:55Z","timestamp":1697570395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11356-020-12200-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":114,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["12200"],"URL":"https:\/\/doi.org\/10.1007\/s11356-020-12200-1","relation":{},"ISSN":["0944-1344","1614-7499"],"issn-type":[{"value":"0944-1344","type":"print"},{"value":"1614-7499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"15 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}